Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE2
94 participants
INTERVENTIONAL
2024-06-24
2025-04-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
BHV-7000
BHV-7000
BHV-7000 75 mg taken once daily
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
BHV-7000
BHV-7000 75 mg taken once daily
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. WOCBP must have a negative urine pregnancy test at Baseline visit.
3. WOCBP must not be breastfeeding or lactating at Baseline visit or any point in the study.
Exclusion Criteria
2. Subjects who, in the opinion of the Investigator, will not be able to adhere to the Schedule of Assessments and/or may have difficulties complying with the treatment regimen over an extended duration of a long-term, outpatient study.
3. Investigator deems subject at imminent risk of danger to others or themself.
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Biohaven Therapeutics Ltd.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pillar Clinical Research, LLC
Bentonville, Arkansas, United States
WIRG
Little Rock, Arkansas, United States
WRN
Rogers, Arkansas, United States
Advanced Research Center, Inc.
Anaheim, California, United States
CIT LA
Bellflower, California, United States
ProScience Research Group
Culver City, California, United States
Cenexel CNS
Garden Grove, California, United States
Synergy San Diego
Lemon Grove, California, United States
NRC Research Institute
Orange, California, United States
CIT IE
Riverside, California, United States
Cenexel CNS
Torrance, California, United States
Segal Trials - Larkin Behavioral Health Services-Inpatient & Early Phase Site
Hollywood, Florida, United States
Cenexel - RCA
Hollywood, Florida, United States
LCC Medical Research Inst
Miami, Florida, United States
Floridian Neuroscience Institute
Miami Lakes, Florida, United States
Segal Trials - Miami Lakes Medical Research-Inpatient & Early Phase Site
Miami Lakes, Florida, United States
Neuroscience Research Institute
West Palm Beach, Florida, United States
Atlanta Center for Medical Research
Atlanta, Georgia, United States
CenExel iResearch, LLC
Decatur, Georgia, United States
CenExel iResearch, LLC
Savannah, Georgia, United States
Uptown Research Institute
Chicago, Illinois, United States
Pillar Clinical Research
Chicago, Illinois, United States
CBH Health
Gaithersburg, Maryland, United States
Precise Clinical Research
Flowood, Mississippi, United States
Arch Clinical Trials
St Louis, Missouri, United States
Hassman Research Institute
Marlton, New Jersey, United States
RBA
Staten Island, New York, United States
Midwest Clinical Research Center
Dayton, Ohio, United States
NBCR
North Canton, Ohio, United States
Community Clinical Research, Inc.
Austin, Texas, United States
InSite Clinical Research, LLC
DeSoto, Texas, United States
Pillar Clinical Research, LLC
Richardson, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BHV7000-202
Identifier Type: -
Identifier Source: org_study_id